Lidocaine Egis

Lidocaine, the active ingredient in Lidocaine Egis, is a local anesthetic presented as a topical preparation for cutaneous use. It provides temporary numbing of the skin and mucous membranes, facilitating pain relief during minor procedures and minor skin irritations in adults and children.

GNH USA supplies Lidocaine Egis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution, ensuring product integrity throughout the supply chain.

Lidocaine is a local anesthetic used to block nerve conduction in the skin.

- Skin surface procedures: provides temporary numbness to facilitate minor surgical or diagnostic interventions. - Minor burns or abrasions: reduces pain during dressing changes. - Venipuncture or cannulation: eases discomfort from needle insertion. - Insect bite relief: alleviates itching and pain from minor insect stings.

Lidocaine may cause a range of adverse reactions, from mild local irritation to rare systemic toxicity.

Common Side Effects: - Localized skin irritation: mild redness at the application site. - Burning or stinging sensation: transient discomfort upon application. - Pruritus: itching of the treated area. - Edema: slight swelling of the skin.

Serious or Rare Side Effects: - Systemic toxicity: dizziness, tinnitus, or seizures if absorbed in large amounts. - Cardiac effects: arrhythmias or hypotension in cases of overdose. - Severe allergic reaction: anaphylaxis or widespread rash.

Before using Lidocaine Egis, consider the following safety measures.

- Allergy assessment: confirm the patient has no known hypersensitivity to lidocaine or related anesthetics. - Application area: limit use to intact skin and avoid large surface areas to reduce systemic absorption. - Mucous membranes: do not apply to eyes, inside the nose, or other mucosal surfaces unless specifically indicated. - Monitoring: observe for signs of systemic toxicity such as CNS or cardiac symptoms during extensive use. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk; consult a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lidocaine can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other local anesthetics: additive toxicity may increase risk of systemic effects. - Class I antiarrhythmics (e.g., quinidine, procainamide): combined use can heighten cardiac conduction disturbances. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic lidocaine levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia that signals lidocaine toxicity. - Diuretics: can elevate plasma concentrations of lidocaine. - Alcohol: may potentiate central nervous system depression when used together.